1. Department of Pharmaceutical Sciences, University of Maryland, Baltimore, Maryland 21201, and Molecular Neuropharmacology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20852-9405